医学伦理研究助手
前沿
论文精读

论文 · 体外 / 类器官研究

微凝胶使iPSCs能够组装、扩增并分化为类器官——从大规模到高通量

Adv Mater · 2026年9月23日 · Klasen 等 9 位作者

问这篇
一分钟了解要点化学定义微凝胶支持iPSC扩增与类器官分化,兼容384孔板高通量流程。

不需要生物学背景,多打比方

正在获取全文并生成讲解(拿不到全文就依据摘要),大约需要 30–60 秒…

已等待 0 秒

这篇还没有动画

动画会把研究的流程、作用机制和关键结果一步一步演示出来,每一步都标明出自原文哪里。制作大约需要 30–60 秒。

目前只拿到了摘要全文暂时拿不到(可能不是免费全文)。下面是论文摘要。

摘要Abstract

摘要第 1 段问这一段

Organoid research holds tremendous potential for personalized medicine and drug development. However, current limitations include reproducibility issues largely due to the use of biologically derived materials, which are prone to batch-to-batch variations. Here, we report a chemically defined microgel-based method for human induced pluripotent stem cell (iPSC)-based organoid generation, enabling expansion of iPSCs and their subsequent differentiation within one construct across different scales, including compatibility with automated 384-well plate workflows. Chemically defined poly(ethylene glycol) (PEG)-based microgels are produced via parallelized step-emulsification microfluidics, enabling scalable production. This approach leverages the self-organization of iPSCs with microgels to build three-dimensional constructs, driven by robust cell-material interactions achieved through vitronectin-coated PEG microgels. This technology allows the iPSCs to expand and retain their pluripotency, after which they can be differentiated into the three germ layers, providing a suitable platform for organoid differentiation. This was further extended by differentiation into cardiac organoids and retinal photoreceptors to demonstrate two exemplary tissues.

这篇对您:
讲解或动画有问题: